Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles

被引:54
作者
Zhou, W
Yuan, X
Wilson, A
Yang, LJ
Mokotoff, M
Pitt, B
Li, S
机构
[1] Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Environm & Occupat Hlth, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA
关键词
D O I
10.1021/bc025569z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this study, a novel lipid vector has been developed for targeted delivery of oligodeoxynucleotides (ODN) to tumors that overexpress folate receptor. This is based on a method developed by Semple et al. (1), which utilizes an ionizable aminolipid (1,2-dioleoyl-3-(dimethylammonio)propane, DODAP) and an ethanol-containing buffer system for encapsulating large quantities of polyanionic ODN in lipid vesicles. Folate is incorporated into the lipid vesicles via a distearoylphosphatidylethanolamine-poly(ethylene glycol) (DSPE-PEG) spacer. These vesicles are around 100-200 nm in diameter with an ODN entrapment efficiency of 60-80%. Folate mediated efficient delivery of ODN to KB cells that overexpress folate receptor. Uptake of folate-targeted lipidic ODN by KB cells is about 8-10-fold more efficient than that of lipidic ODN without a ligand or free ODN. This formulation is resistant to serum. Thus, targeted delivery of ODN via this novel lipid vector may have potential in treating tumors that overexpress folate receptors.
引用
收藏
页码:1220 / 1225
页数:6
相关论文
共 21 条
[1]   Antisense therapeutics [J].
Agrawal, S ;
Zhao, QY .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :519-528
[2]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[3]   Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human cancer cell lines [J].
Ciardiello, F ;
Caputo, R ;
Troiani, T ;
Borriello, G ;
Kandimalla, ER ;
Agrawal, S ;
Mendelsohn, J ;
Bianco, AR ;
Tortora, G .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (02) :172-178
[4]   An overview of progress in antisense therapeutics [J].
Crooke, ST .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (02) :115-122
[5]   MODULATION OF HUMAN PRORENIN GENE-EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES IN TRANSFECTED CHO CELLS [J].
CUMIN, F ;
ASSELBERGS, F ;
LARTIGOT, M ;
FELDER, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 212 (02) :347-354
[6]   Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: In vitro studies [J].
Gabizon, A ;
Horowitz, AT ;
Goren, D ;
Tzemach, D ;
Mandelbaum-Shavit, F ;
Qazen, MM ;
Zalipsky, S .
BIOCONJUGATE CHEMISTRY, 1999, 10 (02) :289-298
[7]   Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells [J].
Grandis, JR ;
Chakraborty, A ;
Melhem, MF ;
Zeng, Q ;
Tweardy, DJ .
ONCOGENE, 1997, 15 (04) :409-416
[8]  
Guo WJ, 1999, J NUCL MED, V40, P1563
[9]   Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer [J].
Lee, RJ ;
Huang, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) :8481-8487
[10]   FOLATE-MEDIATED TUMOR-CELL TARGETING OF LIPOSOME-ENTRAPPED DOXORUBICIN IN-VITRO [J].
LEE, RJ ;
LOW, PS .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1233 (02) :134-144